RPTN

gene
On this page

Also known as FLJ39117

Summary

RPTN (repetin, HGNC:26809) is a protein-coding gene on chromosome 1q21.3, encoding Repetin (Q6XPR3). Involved in the cornified cell envelope formation.

Predicted to enable calcium ion binding activity and transition metal ion binding activity. Predicted to be located in cytosol. Predicted to be active in cornified envelope.

Source: NCBI Gene 126638 — RefSeq curated summary.

At a glance

  • GWAS associations: 18
  • Clinical variants (ClinVar): 111 total
  • MANE Select transcript: NM_001122965

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26809
Approved symbolRPTN
Namerepetin
Location1q21.3
Locus typegene with protein product
StatusApproved
AliasesFLJ39117
Ensembl geneENSG00000215853
Ensembl biotypeprotein_coding
OMIM613259
Entrez126638

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000316073

RefSeq mRNA: 1 — MANE Select: NM_001122965 NM_001122965

CCDS: CCDS41397

Canonical transcript exons

ENST00000316073 — 3 exons

ExonStartEnd
ENSE00001235715152153595152156960
ENSE00001447991152157752152157909
ENSE00001447992152159184152159228

Expression profiles

Bgee: expression breadth broad, 57 present calls, max score 87.89.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1745 / max 107.2182, expressed in 31 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
145360.174531

Top tissues by expression

235 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
gingivaUBERON:000182887.89gold quality
gingival epitheliumUBERON:000194984.31gold quality
tongueUBERON:000172378.36gold quality
body of tongueUBERON:001187674.97gold quality
superior surface of tongueUBERON:000737174.75gold quality
skin of legUBERON:000151173.59gold quality
spermCL:000001972.53silver quality
amniotic fluidUBERON:000017372.39gold quality
epithelium of nasopharynxUBERON:000195172.33gold quality
zone of skinUBERON:000001471.37gold quality
skin of hipUBERON:000155471.10gold quality
nasal cavity epitheliumUBERON:000538468.68silver quality
skin of abdomenUBERON:000141668.21gold quality
oral cavityUBERON:000016766.72gold quality
tonsilUBERON:000237265.68gold quality
upper leg skinUBERON:000426264.62gold quality
mammalian vulvaUBERON:000099761.14silver quality
penisUBERON:000098960.31gold quality
lower esophagus mucosaUBERON:003583453.54gold quality
vaginaUBERON:000099652.27gold quality
esophagus squamous epitheliumUBERON:000692050.81silver quality
ectocervixUBERON:001224950.68gold quality
esophagus mucosaUBERON:000246948.67gold quality
pharyngeal mucosaUBERON:000035545.83gold quality
uterine cervixUBERON:000000245.26gold quality
islet of LangerhansUBERON:000000644.57gold quality
lower lobe of lungUBERON:000894943.44silver quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
nasal cavity mucosaUBERON:000182642.72silver quality
secondary oocyteCL:000065542.57gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

69 targeting RPTN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-807599.9767.20962
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-627-3P99.9071.423316
HSA-MIR-130B-5P99.8368.501888
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-5580-3P99.7069.412052
HSA-MIR-509399.6769.262291
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-4756-3P99.6266.301319
HSA-MIR-7844-5P99.5568.561428
HSA-MIR-427399.4567.931206
HSA-MIR-616599.4467.121389
HSA-MIR-391199.3866.951087
HSA-MIR-1211399.3267.541072
HSA-MIR-2115-3P99.3169.682026
HSA-MIR-580-5P99.2870.941776
HSA-MIR-3191-5P99.2466.521722
HSA-MIR-427999.1966.702437
HSA-MIR-125399.1267.081688
HSA-MIR-877-3P99.0968.101637
HSA-MIR-4711-3P98.9766.871020
HSA-MIR-6760-5P98.8766.731515

Literature-anchored findings (GeneRIF, showing 3)

  • RPTN plays a potential role in emotional and cognitive processing; its decrease in serum may indicate its involvement in the pathogenesis of schizophrenia and bipolar disorder (PMID:25613293)
  • The single-nucleotide polymorphisms of CRNN (rs941934) and RPTN (rs3001978, rs28441202) may contribute to Atopic Dermatitis development, but further studies on a larger group of Atopic Dermatitis patients are needed to verify this assumption. (PMID:28219068)
  • Letter: RPTN gene is associated with straight hair in Europeans and East Asians. Genetics of straight hair may to some degree overlap between these two ancestry groups. (PMID:29935789)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRptnENSMUSG00000041984
rattus_norvegicusRptnENSRNOG00000018679

Paralogs (3): FLG2 (ENSG00000143520), FLG (ENSG00000143631), HRNR (ENSG00000197915)

Protein

Protein identifiers

RepetinQ6XPR3 (reviewed: Q6XPR3)

All UniProt accessions (1): Q6XPR3

UniProt curated annotations — full annotation on UniProt →

Function. Involved in the cornified cell envelope formation. Multifunctional epidermal matrix protein. Reversibly binds calcium.

Subcellular location. Secreted. Extracellular space. Extracellular matrix.

Tissue specificity. Expression is scattered in the normal epidermis but strong in the acrosyringium, the inner hair root sheath and in the filiform papilli of the tongue.

Post-translational modifications. Potential substrate of transglutaminase. Some arginines are probably converted to citrullines by peptidylarginine deimidase.

Domain organisation. Can be divided into a N-terminal domain with significant homology to S100-like calcium-binding proteins, a central domain containing a series of short tandem repeats, and two flanking segments with low homology to the consensus sequences of the central repeats.

Similarity. Belongs to the S100-fused protein family.

RefSeq proteins (1): NP_001116437* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001751S100/CaBP7/8-like_CSConserved_site
IPR002048EF_hand_domDomain
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR013787S100_Ca-bd_subDomain
IPR018247EF_Hand_1_Ca_BSBinding_site
IPR034325S-100_domDomain

Pfam: PF01023

UniProt features (25 total): compositionally biased region 10, binding site 6, region of interest 5, domain 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6XPR3-F142.630.02

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (6): 32; 62; 64; 66; 68; 73

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology
R-HSA-6805567Keratinization

MSigDB gene sets: 72 (showing top): DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, MARTINEZ_RB1_TARGETS_UP, MARTINEZ_RB1_AND_TP53_TARGETS_UP, chr1q21, GOCC_CORNIFIED_ENVELOPE, DODD_NASOPHARYNGEAL_CARCINOMA_DN, RICKMAN_HEAD_AND_NECK_CANCER_E, MARTENS_TRETINOIN_RESPONSE_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE

GO Biological Process (0):

GO Molecular Function (3): calcium ion binding (GO:0005509), transition metal ion binding (GO:0046914), metal ion binding (GO:0046872)

GO Cellular Component (3): cornified envelope (GO:0001533), cytosol (GO:0005829), extracellular region (GO:0005576)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Keratinization1
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
metal ion binding2
cellular anatomical structure2
cation binding1
plasma membrane1
cytoplasm1

Protein interactions and networks

STRING

1403 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RPTNDEPP1Q9NTK1936
RPTNLCE3CQ5T5A8658
RPTNLORICRINP23490608
RPTNTCHHQ07283604
RPTNLCE3BQ5TA77590
RPTNS100ZQ8WXG8571
RPTNLCE5AQ5TCM9518
RPTNFLGP20930515
RPTNLCE3AQ5TA76511
RPTNIVLP07476510
RPTNSPRR2AP35326483
RPTNSPRR4Q96PI1474
RPTNLCE1CQ5T751442
RPTNCRNNQ9UBG3437
RPTNOR51Q1Q8NH59434
RPTNLCE3EQ5T5B0434

IntAct

6 interactions, top by confidence:

ABTypeScore
Ppsi-mi:“MI:0914”(association)0.350
MAP1LC3Bpsi-mi:“MI:0914”(association)0.350
GABARAPL2psi-mi:“MI:0914”(association)0.350
GABARAPL1psi-mi:“MI:0914”(association)0.350
FNDC5A2ML1psi-mi:“MI:0914”(association)0.350

BioGRID (4): RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS)

ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A6NJ88, A6QL64, B4DH59, D3ZVV1, E9Q6E9, F1LWT0, O04492, O88799, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18583, P53353, Q08AG5, Q0P6D6, Q2EG98, Q3BBV2, Q4ZJZ1, Q5HY64, Q5JPF3, Q5QGU6, Q5TAG4, Q5TI25, Q5XHX6, Q6P3W6, Q6P902, Q6XPR3, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8N2N9, Q8N660, Q8N693, Q96EQ9

Diamond homologs: A6QP92, P20930, P37709, P97347, Q07283, Q2VIS4, Q5D862, Q5QJ38, Q6XPR3, Q9D3P1, Q9UBG3, A7K6Y8, A7K6Y9, O77691, O77791, P02632, P02633, P02634, P02638, P02639, P04271, P04631, P05109, P05942, P05943, P05964, P06702, P06703, P07091, P14069, P22793, P23297, P24479, P24480, P25815, P27004, P27005, P28318, P28782, P28783

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

111 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance94
Likely benign16
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

150 predictions. Top by Δscore:

VariantEffectΔscore
1:152156956:GGTCT:Gacceptor_gain1.0000
1:152156957:GTCT:Gacceptor_gain1.0000
1:152156958:TCT:Tacceptor_gain1.0000
1:152156959:CT:Cacceptor_gain1.0000
1:152156959:CTC:Cacceptor_gain1.0000
1:152156960:TCT:Tacceptor_gain1.0000
1:152156961:C:Aacceptor_loss1.0000
1:152156961:C:CCacceptor_gain1.0000
1:152157746:TCTTA:Tdonor_loss1.0000
1:152157747:CTTA:Cdonor_loss1.0000
1:152157748:TTAC:Tdonor_loss1.0000
1:152157749:TA:Tdonor_loss1.0000
1:152157751:C:CTdonor_loss1.0000
1:152157905:TGAAC:Tacceptor_gain1.0000
1:152157907:AAC:Aacceptor_gain1.0000
1:152157908:AC:Aacceptor_gain1.0000
1:152157909:CC:Cacceptor_gain1.0000
1:152157910:C:CCacceptor_gain1.0000
1:152157910:CT:Cacceptor_loss1.0000
1:152156961:C:Gacceptor_gain0.9900
1:152156964:T:Cacceptor_gain0.9900
1:152156964:T:TCacceptor_gain0.9900
1:152157750:A:ACdonor_gain0.9900
1:152157751:C:CCdonor_gain0.9900
1:152157906:GAAC:Gacceptor_gain0.9900
1:152159178:TCTTA:Tdonor_loss0.9900
1:152159179:CTTA:Cdonor_loss0.9900
1:152159180:TTACC:Tdonor_loss0.9900
1:152159181:TAC:Tdonor_loss0.9900
1:152159183:C:CGdonor_loss0.9900

AlphaMissense

5315 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:152157845:G:CF15L0.985
1:152157845:G:TF15L0.985
1:152157847:A:GF15L0.985
1:152156886:A:CF71L0.975
1:152156886:A:TF71L0.975
1:152156888:A:GF71L0.975
1:152156862:G:CF79L0.967
1:152156862:G:TF79L0.967
1:152156864:A:GF79L0.967
1:152157783:A:GL36P0.965
1:152156879:A:CY74D0.964
1:152156879:A:GY74H0.964
1:152156878:T:GY74S0.963
1:152157792:A:GL33S0.955
1:152156887:A:GF71S0.952
1:152156875:A:GL75P0.951
1:152156849:C:GA84P0.949
1:152157780:A:GL37P0.949
1:152157846:A:GF15S0.944
1:152156857:A:GL81S0.940
1:152156917:A:GL61S0.934
1:152157767:A:CF41L0.933
1:152157767:A:TF41L0.933
1:152157769:A:GF41L0.933
1:152157867:A:TI8K0.933
1:152157788:T:AK34N0.930
1:152157788:T:GK34N0.930
1:152156879:A:TY74N0.929
1:152157780:A:TL37H0.929
1:152157756:A:GL45P0.925

dbSNP variants (sampled 300 via entrez): RS1000437682 (1:152159010 A>T), RS1000477799 (1:152155338 C>G), RS1001343280 (1:152156412 A>G), RS1002242149 (1:152157014 G>A,T), RS1003780838 (1:152158141 A>G), RS1003957986 (1:152159487 T>C), RS1004687003 (1:152154662 C>T), RS1004984886 (1:152159308 G>A), RS1005967736 (1:152160209 T>C), RS1006198385 (1:152158242 C>G,T), RS1006539203 (1:152154270 C>T), RS1006865090 (1:152154985 G>T), RS1007309974 (1:152155001 C>T), RS1007645567 (1:152160965 A>G), RS1008045936 (1:152160487 G>A)

Disease associations

OMIM: gene MIM:613259 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

18 associations (top):

StudyTraitp-value
GCST004861_28Itch intensity from mosquito bite3.000000e-08
GCST005038_8Allergic disease (asthma, hay fever or eczema)7.000000e-17
GCST006661_183Male-pattern baldness1.000000e-10
GCST007563_33Allergic disease (asthma, hay fever or eczema)3.000000e-11
GCST007564_24Asthma or allergic disease (pleiotropy)5.000000e-12
GCST007797_16Asthma onset (childhood vs adult)8.000000e-24
GCST007798_7Asthma4.000000e-24
GCST007800_52Asthma (childhood onset)8.000000e-48
GCST008916_82Asthma5.000000e-27
GCST008916_88Asthma1.000000e-25
GCST009798_26Asthma2.000000e-21
GCST009798_76Asthma1.000000e-22
GCST010984_48Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)6.000000e-19
GCST010985_2Allergic disease (asthma, hay fever and/or eczema) (age of onset)3.000000e-48
GCST011053_6Neuroblastoma (pediatric)8.000000e-23
GCST011379_1Cutaneous mastocytosis (childhood)4.000000e-09
GCST011381_4Cutaneous mastocytosis3.000000e-11
GCST011383_4Mastocytosis8.000000e-12

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008377mosquito bite reaction itch intensity measurement
EFO:0004847age at onset

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
Nickeldecreases expression, affects expression, decreases reaction3
hydroquinoneincreases expression2
Sodium Dodecyl Sulfatedecreases expression, increases expression2
Tetrachlorodibenzodioxinincreases expression2
urushiolincreases expression1
sodium arsenatedecreases expression, increases abundance1
trichostatin Aaffects expression, decreases reaction1
sodium arsenitedecreases expression1
avobenzonedecreases expression1
CGP 52608affects binding, increases reaction1
Antimony Potassium Tartratedecreases expression1
Arsenicdecreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Coal Tarincreases expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
Aflatoxin B1decreases methylation1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.